The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

Maurizio Averna, Luis Masana, Kausik K Ray, Robert A Hegele, Raul D Santos, Eric Bruckert, Steve E Humphries, Marja-Riitta Taskinen, Jan Borén, G Kees Hovingh, Jan Albert Kuivenhoven, Päivi Pajukanta, Olivier S Descamps, Frederick J Raal, Erik Stroes, Anne Tybjærg-Hansen, Olov Wiklund, Klaus G Parhofer, Alberico L Catapano, Børge G NordestgaardPetri T Kovanen, Anton F H Stalenhoef, Henry N Ginsberg, Gerald F Watts, M John Chapman

Risultato della ricerca: Article

248 Citazioni (Scopus)

Abstract

Plasma triglyceride concentration is a biomarker for circulating triglyceride-rich lipoproteins and their metabolic remnants. Common mild-to-moderate hypertriglyceridaemia is typically multigenic, and results from the cumulative burden of common and rare variants in more than 30 genes, as quantified by genetic risk scores. Rare autosomal recessive monogenic hypertriglyceridaemia can result from large-effect mutations in six different genes. Hypertriglyceridaemia is exacerbated by non-genetic factors. On the basis of recent genetic data, we redefine the disorder into two states: severe (triglyceride concentration >10 mmol/L), which is more likely to have a monogenic cause; and mild-to-moderate (triglyceride concentration 2-10 mmol/L). Because of clustering of susceptibility alleles and secondary factors in families, biochemical screening and counselling for family members is essential, but routine genetic testing is not warranted. Treatment includes management of lifestyle and secondary factors, and pharmacotherapy. In severe hypertriglyceridaemia, intervention is indicated because of pancreatitis risk; in mild-to-moderate hypertriglyceridaemia, intervention can be indicated to prevent cardiovascular disease, dependent on triglyceride concentration, concomitant lipoprotein disturbances, and overall cardiovascular risk.
Lingua originaleEnglish
pagine (da-a)655-666
Numero di pagine12
RivistaTHE LANCET DIABETES & ENDOCRINOLOGY
Volume2
Stato di pubblicazionePublished - 2013

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cita questo

Averna, M., Masana, L., Ray, K. K., Hegele, R. A., Santos, R. D., Bruckert, E., Humphries, S. E., Taskinen, M-R., Borén, J., Hovingh, G. K., Kuivenhoven, J. A., Pajukanta, P., Descamps, O. S., Raal, F. J., Stroes, E., Tybjærg-Hansen, A., Wiklund, O., Parhofer, K. G., Catapano, A. L., ... Chapman, M. J. (2013). The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. THE LANCET DIABETES & ENDOCRINOLOGY, 2, 655-666.